New test measures effectiveness of treatments for Huntington's disease
(University of British Columbia) A new test developed by UBC researchers allows physicians to measure the effects of gene silencing therapy in Huntington's disease and will support the first human clinical trial of a drug that targets the genetic cause of the disease.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Clinical Trials | Genetics | Health | Huntington's Disease | International Medicine & Public Health